“bristol-myers-squibb” Archives

Entry Author Date Location
Big Bucks, Tiny Bubbles: Ex-Biogen Exec’s Exosome Startup Nabs $80M 11/17/15 Boston
East Coast Biotech Roundup: Bluebird, Solid GT, Evelo, Dyax & More 11/09/15 Boston
Bristol-Myers to Add Cardioxyl’s Heart Failure Drug With $300M Deal 11/02/15 Raleigh Durham
East Coast Biotech Roundup: Zafgen, Decibel, Voyager & More 10/16/15 Boston
Five Prime, Bristol Shake Hands Again in New $350M Cancer Pact 10/15/15 San Francisco
East Coast Biotech Roundup: Forum, Neon, Sarepta, Accelerator & More 10/02/15 Boston
East Coast Biotech Roundup: X4, Rgenix, Alnylam, Intellia & More 09/04/15 Boston
Bristol-Myers Makes $150M Bet on Promedior, Fibrosis Drug 08/31/15 Boston
New CEO and $80M Later, Syndax Looks Prepped for Second IPO Try 08/24/15 Boston
East Coast Biotech Roundup: Editas, Checkmate, Ovid & More 08/14/15 Boston
Ex-Teva CEO’s Brain Disease Startup, Ovid, Bags $75M From Crossovers 08/11/15 New York
Drug Discovery in Seattle 2015: An Updated History 08/03/15 Seattle
Sanofi, Regeneron Set Sights on Immuno-Oncology With New $2B+ Pact 07/28/15 New York
Beer Out as Struggling Aegerion Shuffles Leadership Ranks 07/27/15 Boston
East Coast Biotech Roundup: Biogen, RaNA, Inotek, Disruptors & More 07/24/15 Boston
Biogen R&D Chief Doug Williams Leaves to Run New Cancer Startup 07/10/15 Boston
East Coast Biotech Roundup: Flagship, SQZ, Epizyme, IPOs & More 06/26/15 Boston
ASCO Roundup: Checkpoints, Pushback Against Prices, CAR-T & More 06/02/15 National
Ex-AstraZeneca Exec to Lead Surface’s “Next-Gen” Immuno-Oncology Plan 05/07/15 Boston
Adaptive Reels in Whopping $195M For Immuno-Sequencing Work 05/06/15 Seattle
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
East Coast Biotech Roundup: Forum, Crossovers, Immuno-Oncology & More 04/24/15 Boston
ImmuneXcite Enlists Body’s First Defender for Immune Attack on Cancer 04/21/15 Boston
Hunting for an IPO? Voyager Gets $60M From “Crossover” Backers 04/13/15 Boston
East Coast Biotech Roundup: Cellectis, Bristol, What’s Hot & More 04/13/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
Pivoting From IPO, Syndax Inks Combo Trial Deal With Merck 03/31/15 Boston
East Coast Biotech Roundup: Hemophilia, Levin, Vertex, Semma & More 03/27/15 Boston
Ex-Teva CEO Levin Is Back With Startup Aimed at Rare Neuro Disorders 03/25/15 New York
East Coast Biotech Roundup: Sync Project, Epizyme, Bristol & More 03/16/15 Boston
Page 1 of 12 next page »